Voyager Therapeutics (VYGR) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to -$418.5 million.
- Voyager Therapeutics' Retained Earnings fell 4346.93% to -$418.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$418.5 million, marking a year-over-year decrease of 4346.93%. This contributed to the annual value of -$326.2 million for FY2024, which is 2488.76% down from last year.
- As of Q3 2025, Voyager Therapeutics' Retained Earnings stood at -$418.5 million, which was down 4346.93% from -$390.6 million recorded in Q2 2025.
- Voyager Therapeutics' Retained Earnings' 5-year high stood at -$261.2 million during Q4 2023, with a 5-year trough of -$418.5 million in Q3 2025.
- Over the past 5 years, Voyager Therapeutics' median Retained Earnings value was -$327.7 million (recorded in 2021), while the average stood at -$332.8 million.
- In the last 5 years, Voyager Therapeutics' Retained Earnings surged by 3362.79% in 2023 and then crashed by 4346.93% in 2025.
- Quarter analysis of 5 years shows Voyager Therapeutics' Retained Earnings stood at -$347.1 million in 2021, then dropped by 13.37% to -$393.5 million in 2022, then soared by 33.63% to -$261.2 million in 2023, then fell by 24.89% to -$326.2 million in 2024, then decreased by 28.3% to -$418.5 million in 2025.
- Its last three reported values are -$418.5 million in Q3 2025, -$390.6 million for Q2 2025, and -$357.2 million during Q1 2025.